Dow Down0.13% Nasdaq Up0.14%

Nivalis Therapeutics, Inc. (NVLS)

-NasdaqGM
4.67 Down 0.35(6.97%) May 26, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development16,054  12,200  13,136  
Selling General and Administrative6,844  2,287  2,141  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (22,898) (14,487) (15,277)
Income from Continuing Operations
Total Other Income/Expenses Net80  674  10  
Earnings Before Interest And Taxes(22,818)(14,191)(15,267)
Interest Expense -  845  931  
Income Before Tax(22,818)(15,036)(16,198)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(22,818)(14,658)(16,198)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (22,818) (14,658) (16,198)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (22,818) (14,658) (16,198)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.